These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6641470)
1. Phencyclidine: effects on the fetus and neonate. Chasnoff IJ; Burns WJ; Hatcher RP; Burns KA Dev Pharmacol Ther; 1983; 6(6):404-8. PubMed ID: 6641470 [TBL] [Abstract][Full Text] [Related]
2. Pentazocine and tripelennamine ('T's and blue's'): effects on the fetus and neonate. Chasnoff IJ; Hatcher R; Burns WJ; Schnoll SH Dev Pharmacol Ther; 1983; 6(3):162-9. PubMed ID: 6861602 [TBL] [Abstract][Full Text] [Related]
4. Neonatal manifestations of maternal phencyclidine exposure. Golden NL; Kuhnert BR; Sokol RJ; Martier S; Williams T J Perinat Med; 1987; 15(2):185-91. PubMed ID: 3656050 [TBL] [Abstract][Full Text] [Related]
5. What happens to babies exposed to phencyclidine (PCP) in utero? Wachsman L; Schuetz S; Chan LS; Wingert WA Am J Drug Alcohol Abuse; 1989; 15(1):31-9. PubMed ID: 2923109 [TBL] [Abstract][Full Text] [Related]
6. Angel dust: possible effects on the fetus. Golden NL; Sokol RJ; Rubin IL Pediatrics; 1980 Jan; 65(1):18-20. PubMed ID: 7355023 [TBL] [Abstract][Full Text] [Related]
7. Perinatal outcome associated with PCP versus cocaine use. Tabor BL; Smith-Wallace T; Yonekura ML Am J Drug Alcohol Abuse; 1990; 16(3-4):337-48. PubMed ID: 2288331 [TBL] [Abstract][Full Text] [Related]
8. Cranial ultrasound abnormalities identified at birth: their relationship to perinatal risk and neurobehavioral outcome. Behnke M; Eyler FD; Garvan CW; Tenholder MJ; Wobie K; Woods NS; Conlon M; Cumming W Pediatrics; 1999 Apr; 103(4):e41. PubMed ID: 10103333 [TBL] [Abstract][Full Text] [Related]
9. Impact of intrauterine exposure to phencyclidine (PCP) and cocaine on neonates. Rahbar F; Fomufod A; White D; Westney LS J Natl Med Assoc; 1993 May; 85(5):349-52. PubMed ID: 8496988 [TBL] [Abstract][Full Text] [Related]
10. Right to healthy birth: medico-legal issues in phencyclidine ingestion. Kaufman KR; Weekes ME; Kaufman ER Child Abuse Negl; 1986; 10(1):41-4. PubMed ID: 3955427 [TBL] [Abstract][Full Text] [Related]
12. Prenatal drug exposure: effects on neonatal and infant growth and development. Chasnoff IJ; Burns KA; Burns WJ; Schnoll SH Neurobehav Toxicol Teratol; 1986; 8(4):357-62. PubMed ID: 3762846 [TBL] [Abstract][Full Text] [Related]
13. Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate. Chasnoff IJ; Burns WJ; Schnoll SH NIDA Res Monogr; 1984 Mar; 49():220-6. PubMed ID: 6434963 [No Abstract] [Full Text] [Related]
14. Cocaine use in pregnancy. Chasnoff IJ; Burns WJ; Schnoll SH; Burns KA N Engl J Med; 1985 Sep; 313(11):666-9. PubMed ID: 4022059 [TBL] [Abstract][Full Text] [Related]
15. Phencyclidine and chemical "stroking". Alexander RL J Natl Med Assoc; 1980 Sep; 72(9):845-50. PubMed ID: 7191444 [TBL] [Abstract][Full Text] [Related]
16. Relationship of phencyclidine and pregnancy outcome. Mvula MM; Miller JM; Ragan FA J Reprod Med; 1999 Dec; 44(12):1021-4. PubMed ID: 10649812 [TBL] [Abstract][Full Text] [Related]
17. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Lewis AJ; Galbally M; Opie G; Buist A Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792 [TBL] [Abstract][Full Text] [Related]
18. Cocaine use in pregnancy: perinatal morbidity and mortality. Chasnoff IJ; Burns KA; Burns WJ Neurotoxicol Teratol; 1987; 9(4):291-3. PubMed ID: 3683346 [TBL] [Abstract][Full Text] [Related]
19. Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain. Ali SF; Ahmad G; Slikker W; Bondy SC Neurotoxicology; 1989; 10(3):383-92. PubMed ID: 2576301 [TBL] [Abstract][Full Text] [Related]